Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting farnesyltransferase: is Ras relevant?

George C. Prendergast1, Wei Du

  • 1The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 16, 2001
PubMed
Summary

Farnesyltransferase inhibitors (FTIs) show promise as cancer therapeutics by altering Rho GTPase activity, potentially reversing malignant phenotypes. This suggests a new therapeutic strategy beyond targeting Ras protein.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Preparation of surface molecularly imprinted polymers for penicilloic acid, and its adsorption properties].

Se pu = Chinese journal of chromatography·2016
Same author

Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells.

Oncology letters·2016
Same author

Rapid three-dimensional microfluidic mixer for high viscosity solutions to unravel earlier folding kinetics of G-quadruplex under molecular crowding conditions.

Talanta·2016
Same author

[A review on microRNAs regulation in osteoclast differentiation and function].

Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology·2015
Same author

Two-Way Fluid-Gas Exchange Syringe for Postvitrectomy Patients in Outpatient Setting.

Retina (Philadelphia, Pa.)·2015
Same author

[Progress and prospect of biodiesel industry in China].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2015

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Farnesyltransferase inhibitors (FTIs) were developed as cancer therapeutics targeting the oncogenic Ras protein.
  • Preclinical studies show FTIs are non-toxic and can reverse malignant phenotypes.
  • Emerging evidence suggests FTIs' anti-transforming effects may involve Rho GTPase, not solely Ras.

Purpose of the Study:

  • To review recent developments in FTI research.
  • To discuss the role of Rho GTPase in FTI efficacy.
  • To explore the impact of these findings on clinical trial design.

Main Methods:

  • Literature review of preclinical and clinical studies on Farnesyltransferase inhibitors.
  • Analysis of molecular mechanisms underlying FTI action, focusing on Ras and Rho GTPases.

Related Experiment Videos

  • Discussion of implications for cancer therapeutic strategies and clinical trial design.

    • Main Results:

    • FTIs exhibit anti-cancer properties through mechanisms potentially independent of Ras inhibition.
    • Alteration of Rho GTPase activity is implicated in the antitransforming effects of FTIs.
    • These findings necessitate a re-evaluation of FTI mechanisms and clinical trial strategies.

    Conclusions:

    • The therapeutic mechanisms of FTIs may extend beyond Ras inhibition to include modulation of Rho GTPase.
    • Understanding the role of Rho is critical for optimizing FTI-based cancer therapies.
    • Future clinical trials should consider Rho-related pathways in their design and evaluation of FTIs.